Literature DB >> 29616090

Clinical value and potential pathways of miR-183-5p in bladder cancer: A study based on miRNA-seq data and bioinformatics analysis.

Jia-Min Gao1,2,3,4, Lin-Zhen Huang1,2,4,5, Zhi-Guang Huang1,2,4,5, Rong-Quan He1,2,3,4.   

Abstract

The clinicopathological value and exploration of the potential molecular mechanism of microRNA-183-5p (miR-183-5p) have been investigated in various cancers; however, to the best of the author's knowledge, no similar research has been reported for bladder cancer. In the present study, it was revealed that the expression level of miR-183-5p was notably increased in bladder cancer tissues compared with adjacent non-cancerous tissues (P=0.001) and was markedly increased in the tissue samples of papillary, pathological T stage (T0-T2) and pathological stage (I-II) compared with tissue samples of their counterparts (P=0.05), according to data from The Cancer Genome Atlas. Receiver operating characteristic analysis revealed the robust diagnostic value of miR-183-5p for distinguishing bladder cancer from non-cancerous bladder tissues (area under curve=0.948; 95% confidence interval: 0.919-0.977). Amplification and deep deletion of miR-183-5p were indicated by cBioPortal, accounting for 1% (4/412) of bladder cancer cases. Data from YM500v3 demonstrated that compared with other cancers, bladder cancer exhibited high expression levels of miR-183-5p, and miR-183-5p expression in primary solid tumors was much higher compared with solid normal tissues. A meta-analysis indicated that miR-183-5p was more highly expressed in bladder cancer samples compared with normal counterparts. A total of 88 potential target genes of miR-183-5p were identified, 13 of which were discerned as hub genes by protein-protein interaction. The epithelial-to-mesenchymal transition pathway was the most significantly enriched pathway by FunRich (P=0.0001). In summary, miR-183-5p may participate in the tumorigenesis and development of bladder cancer via certain signaling pathways, particularly the epithelial-to-mesenchymal transition pathway. However, the exact molecular mechanism of miR-183-5p in bladder cancer must be validated by in vitro and in vivo experiments.

Entities:  

Keywords:  amplification; bladder cancer; diagnosis; hub genes; miR-183-5p

Year:  2018        PMID: 29616090      PMCID: PMC5876500          DOI: 10.3892/ol.2018.7967

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  47 in total

1.  Colorectal cancer statistics, 2017.

Authors:  Rebecca L Siegel; Kimberly D Miller; Stacey A Fedewa; Dennis J Ahnen; Reinier G S Meester; Afsaneh Barzi; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2017-03-01       Impact factor: 508.702

2.  MicroRNA-183 Functions As an Oncogene by Regulating PDCD4 in Gastric Cancer.

Authors:  Chenglong Li; Li Deng; Qiaoming Zhi; Qingyou Meng; Aimin Qian; Hongfei Sang; Xiaoqiang Li; Jiazeng Xia
Journal:  Anticancer Agents Med Chem       Date:  2016       Impact factor: 2.505

3.  Characterization of microRNAs expression profiling in one group of Chinese urothelial cell carcinoma identified by Solexa sequencing.

Authors:  Yu-Hua Chen; Si-Qi Wang; Xiu-Ling Wu; Mo Shen; Zhan-Guo Chen; Xiao-Gang Chen; Yong-Xia Liu; Xiao-Li Zhu; Fei Guo; Xiu-Zhi Duan; Xiu-Cui Han; Zhi-Hua Tao
Journal:  Urol Oncol       Date:  2011-07-27       Impact factor: 3.498

4.  Association detection between genetic variants in the microRNA binding sites of toll-like receptors signaling pathway genes and bladder cancer susceptibility.

Authors:  Sihang Cheng; Jiaming Liu; Yonggang Zhang; Yifei Lin; Qinyu Liu; Hong Li; Jin Huang; Peng Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

5.  Higher Expression of miR-182 in Cytology Specimens of High-Grade Urothelial Cell Carcinoma: A Potential Diagnostic Marker.

Authors:  Shuanzeng Wei; Zhanyong Bing; Yuan Yao; Stephen R Master; Prabodh Gupta
Journal:  Acta Cytol       Date:  2015-02-12       Impact factor: 2.319

6.  Up-regulation of microRNA-183-3p is a potent prognostic marker for lung adenocarcinoma of female non-smokers.

Authors:  F Xu; H Zhang; Y Su; J Kong; H Yu; B Qian
Journal:  Clin Transl Oncol       Date:  2014-05-08       Impact factor: 3.405

7.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data.

Authors:  Mark D Robinson; Davis J McCarthy; Gordon K Smyth
Journal:  Bioinformatics       Date:  2009-11-11       Impact factor: 6.937

8.  The miR-130 family promotes cell migration and invasion in bladder cancer through FAK and Akt phosphorylation by regulating PTEN.

Authors:  Hiroshi Egawa; Kentaro Jingushi; Takayuki Hirono; Yuko Ueda; Kaori Kitae; Wataru Nakata; Kazutoshi Fujita; Motohide Uemura; Norio Nonomura; Kazutake Tsujikawa
Journal:  Sci Rep       Date:  2016-02-03       Impact factor: 4.379

Review 9.  Diagnostic Value of MicroRNAs for Urologic Cancers: A Systematic Review and Meta-Analysis.

Authors:  Hui Ouyang; Yanzhao Zhou; Li Zhang; Guanxin Shen
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

10.  MiR-200c promotes bladder cancer cell migration and invasion by directly targeting RECK.

Authors:  Yidong Cheng; Xiaolei Zhang; Peng Li; Chengdi Yang; Jinyuan Tang; Xiaheng Deng; Xiao Yang; Jun Tao; Qiang Lu; Pengchao Li
Journal:  Onco Targets Ther       Date:  2016-08-16       Impact factor: 4.147

View more
  13 in total

Review 1.  MicroRNAs: Key Players in Bladder Cancer.

Authors:  Qi Li; Helei Wang; Hourong Peng; Qiuping Huang; Ting Huyan; Qingsheng Huang; Hui Yang; Junling Shi
Journal:  Mol Diagn Ther       Date:  2019-10       Impact factor: 4.074

2.  Clinical values and potential pathways of miR-183-5p in gastric cancer: a study based on integrational bioinformatics analysis.

Authors:  Yanan Wang; Jinku Zhang; Mingkai Liu; Shun Zhang; Weina Wang; Shujie Cheng
Journal:  J Gastrointest Oncol       Date:  2021-10

3.  Urinary exosomal microRNA-96-5p and microRNA-183-5p expression as potential biomarkers of bladder cancer.

Authors:  Amal S El-Shal; Sally M Shalaby; Safwat E Abouhashem; Eman H Abd Elbary; Samir Azazy; Nearmeen M Rashad; Walaa Sarhan
Journal:  Mol Biol Rep       Date:  2021-06-04       Impact factor: 2.316

4.  Identification of exosomal and non‑exosomal microRNAs associated with the drug resistance of ovarian cancer.

Authors:  Yiwen Feng; Wenzhao Hang; Zhenyu Sang; Shuangdi Li; Wei Xu; Yi Miao; Xiaowei Xi; Qian Huang
Journal:  Mol Med Rep       Date:  2019-03-05       Impact factor: 2.952

5.  Exosomal miR-183-5p promotes angiogenesis in colorectal cancer by regulation of FOXO1.

Authors:  Anquan Shang; Xuan Wang; Chenzheng Gu; Wenfang Liu; Junjun Sun; Bingjie Zeng; Chen Chen; Ping Ji; Junlu Wu; Wenqiang Quan; Yiwen Yao; Weiwei Wang; Zujun Sun; Dong Li
Journal:  Aging (Albany NY)       Date:  2020-05-03       Impact factor: 5.682

6.  miR-205-3p promotes proliferation and reduces apoptosis of breast cancer MCF-7 cells and is associated with poor prognosis of breast cancer patients.

Authors:  Changhong Qiu; Fei Huang; Qing Zhang; Wei Chen; Huiting Zhang
Journal:  J Clin Lab Anal       Date:  2019-10-02       Impact factor: 2.352

7.  RETRACTED: LSAMP-AS1 binds to microRNA-183-5p to suppress the progression of prostate cancer by up-regulating the tumor suppressor DCN.

Authors:  Xing Hua; Zhen Liu; Min Zhou; Yan Tian; Pei-Pei Zhao; Wen-Hai Pan; Chao-Xia Li; Xiao-Xiao Huang; Ze-Xiao Liao; Qi Xian; Bo Chen; Yue Hu; Lei Leng; Xiao-Wei Fang; Li-Na Yu
Journal:  EBioMedicine       Date:  2019-11-12       Impact factor: 8.143

8.  Bioinformatic Identification of miR-622 Key Target Genes and Experimental Validation of the miR-622-RNF8 Axis in Breast Cancer.

Authors:  Chuanyang Liu; Lu Min; Jingyu Kuang; Chushu Zhu; Xin-Yuan Qiu; Lingyun Zhu
Journal:  Front Oncol       Date:  2019-10-23       Impact factor: 6.244

9.  Urinary expression of let-7c cluster as non-invasive tool to assess the risk of disease progression in patients with high grade non-muscle invasive bladder Cancer: a pilot study.

Authors:  Manuela Spagnuolo; Manuela Costantini; Mariaconsiglia Ferriero; Marco Varmi; Isabella Sperduti; Giulia Regazzo; Lucia Cicchillitti; Ana Belén Díaz Méndez; Giovanni Cigliana; Vincenzo Pompeo; Andrea Russo; Valentina Laquintana; Riccardo Mastroianni; Giulia Piaggio; Umberto Anceschi; Aldo Brassetti; Alfredo Bove; Gabriele Tuderti; Rocco Simone Flammia; Michele Gallucci; Giuseppe Simone; Maria Giulia Rizzo
Journal:  J Exp Clin Cancer Res       Date:  2020-04-17

10.  HDAC-Linked "Proliferative" miRNA Expression Pattern in Pancreatic Neuroendocrine Tumors.

Authors:  Eckhard Klieser; Romana Urbas; Stefan Swierczynski; Stefan Stättner; Florian Primavesi; Tarkan Jäger; Christian Mayr; Tobias Kiesslich; Pietro Di Fazio; Katharina Helm; Daniel Neureiter
Journal:  Int J Mol Sci       Date:  2018-09-15       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.